Mark Daly

Director/Board Member presso CIPLA QUALITY CHEMICAL INDUSTRIES LTD

44 anni

Health Technology

Consumer Services

Profilo

Mark Warwick Daly currently works at Cipla Quality Chemical Industries Ltd., as Non-Executive Director from 2018.
Mr. Daly also formerly worked at Cipla Medpro South Africa (Pty) Ltd., as Chief Financial Officer, Secretary & Director.
Mr. Daly received his undergraduate degree from University of Natal.

Posizioni attive di Mark Daly

Società	Posizione	Inizio
CIPLA QUALITY CHEMICAL INDUSTRIES LTD	Director/Board Member	14/04/2018

Tutte le posizioni attive di Mark Daly

Precedenti posizioni note di Mark Daly

Società	Posizione	Fine
Cipla Medpro South Africa (Pty) Ltd. Cipla Medpro South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Cipla Medpro South Africa Ltd. engages in the business of manufacturing, marketing and supply of pharmaceutical products. It provides medicines and products for the cure of diseases such as cardio-respiratory, diabetes, oncology, neuro-psychiatry and human immunodeficiency virus and acquired immune deficiency syndrome. The company was founded in 2003 and is headquartered in Cape Town, South Africa.	Director of Finance/CFO	-

Vedi nel dettaglio l'esperienza di Mark Daly

Formazione di Mark Daly

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mark Daly

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CIPLA QUALITY CHEMICAL INDUSTRIES LTD	Health Technology

Aziende private	2
University of Natal	Consumer Services
Cipla Medpro South Africa (Pty) Ltd. Cipla Medpro South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Cipla Medpro South Africa Ltd. engages in the business of manufacturing, marketing and supply of pharmaceutical products. It provides medicines and products for the cure of diseases such as cardio-respiratory, diabetes, oncology, neuro-psychiatry and human immunodeficiency virus and acquired immune deficiency syndrome. The company was founded in 2003 and is headquartered in Cape Town, South Africa.	Health Technology